Features

Once again, the annual Drug Delivery to the Lung (DDL) conference drew approximately 1,000 inhaled and nasal drug delivery experts to the Edinburgh International Conference Centre, with an additional 100 delegates attending online. With a… Read more . . .

Nebulizer maker HCMed, in partnership with several other OINDP-related organizations, has organized a new pitch day called RespireX that will debut in March 2026. Aimed at providing early stage start-ups or academic groups with support… Read more . . .

The 2025 edition of the Drug Delivery to the Lungs (DDL) meeting is once again expected to draw approximately 1,100 inhaled and nasal drug delivery experts to the Edinburgh International Conference Centre (EICC). The conference,… Read more . . .

RDD Europe 2025, which took place in Estoril, Portugal May 6-9, welcomed approximately 490 delegates and 70 exhibitors from around the world to a meeting that focused on overcoming complex problems in order to advance inhaled… Read more . . .

The upcoming RDD Europe 2025 conference in Estoril, Portugal will mark the 20th anniversary of the first RDD Europe meeting, which took place in Paris in 2005. Co-organized by RDD Online and Aptar Pharma, the… Read more . . .

DDL 2024 drew the largest crowd ever in the 35-year history of the Drug Delivery to the Lung (DDL), with more than 100 OINDP experts attending online and approximately 1,000 attending in person at the… Read more . . .

The annual Drug Delivery to the Lungs (DDL) conference will mark its 35th anniversary during this year’s meeting, which will take place December 11-13 at the Edinburgh International Conference Centre (EICC). Organizers have set a… Read more . . .

A striking feature of recent batches of OINDP product specific guidances (PSGs) is the inclusion of strategies for the demonstration of bioequivalence (BE) that eliminate the need for a clinical endpoint trial. Copley Applications Specialist… Read more . . .

By Yvonne Limpens, Managing Human Factors Specialist at Emergo by UL While the time to market for generic inhalers is much shorter compared to novel inhalers because there is no requirement for generic product manufacturers… Read more . . .

RDD 2024, which took place May 5-9 in Tucson, AZ, USA, brought together more than 530 delegates and 70 exhibitors for a meeting that highlighted a number of transitions taking place in the development of OINDPs. Compared… Read more . . .